We are analyzing https://link.springer.com/article/10.1007/s12264-012-1263-1.

Title:
Dysfunction of two lysosome degradation pathways of α-synuclein in Parkinson’s disease: potential therapeutic targets? | Neuroscience Bulletin
Description:
Parkinson’s disease (PD) is pathologically characterized by the presence of α-synuclein (α-syn)-positive intracytoplasmic inclusions named Lewy bodies in the dopaminergic neurons of the substantia nigra. A series of morbid consequences are caused by pathologically high amounts or mutant forms of α-syn, such as defects of membrane trafficking and lipid metabolism. In this review, we consider evidence that both point mutation and overexpression of α-syn result in aberrant degradation in neurons and microglia, and this is associated with the autophagy-lysosome pathway and endosome-lysosome system, leading directly to pathological intracellular aggregation, abnormal externalization and re-internalization cycling (and, in turn, internalization and re-externalization), and exocytosis. Based on these pathological changes, an increasing number of researchers have focused on these new therapeutic targets, aiming at alleviating the pathological accumulation of α-syn and re-establishing normal degradation.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

article, google, scholar, pubmed, cas, disease, αsynuclein, parkinsons, alphasynuclein, autophagy, lee, cell, neurosci, degradation, privacy, cookies, content, chen, lewy, access, plos, publish, research, search, lysosome, potential, therapeutic, microglia, pathway, body, neuronal, release, biol, model, data, information, log, journal, dysfunction, targets, jiang, shengdi, neurons, αsyn, pathological, aggregation, exocytosis, neurodegeneration, transmission, subjects,

Topics {✒️}

month download article/chapter sheng-di chen disease-related a53t alpha-synuclein a53t alpha-synuclein mutation chaperone-mediated autophagy α-synuclein impairs macroautophagy cell-produced alpha-synuclein alpha-synuclein protein article jiang full article pdf synuclein activates microglia aggregated alpha-synuclein privacy choices/manage cookies decreased alpha-synuclein alpha-synuclein neuropathology autophagy autophagosomes er mutant alpha-synuclein α-synuclein isoform α-synuclein immunoreactivity monomeric α-synuclein extracellular α-synuclein trafficof α-synuclein lewy body diseases establishing normal degradation alpha-synuclein models lysosome degradation pathways endosome-lysosome system α-synuclein overexpression lewy body disease european economic area formic acid pretreatment single-molecule level maguire-zeiss ka calcium-dependent manner atg1/ulk1 complex selective molecular alterations hsp90 regulate recycling ruijin hospital affiliated autophagy-lysosome pathway conditions privacy policy α-syn result pathologically high amounts potential therapeutic applications endocytic pathway abnormality lipid raft interaction disease-linked mutants autophagy fights disease impacts neuronal survival potential therapeutic targets article log

Questions {❓}

Dysfunction of two lysosome degradation pathways of α-synuclein in Parkinson’s disease: potential therapeutic targets?
Dysfunction of two lysosome degradation pathways of α-synuclein in Parkinson’s disease: potential therapeutic targets?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Dysfunction of two lysosome degradation pathways of α-synuclein in Parkinson’s disease: potential therapeutic targets?
         description:Parkinson’s disease (PD) is pathologically characterized by the presence of α-synuclein (α-syn)-positive intracytoplasmic inclusions named Lewy bodies in the dopaminergic neurons of the substantia nigra. A series of morbid consequences are caused by pathologically high amounts or mutant forms of α-syn, such as defects of membrane trafficking and lipid metabolism. In this review, we consider evidence that both point mutation and overexpression of α-syn result in aberrant degradation in neurons and microglia, and this is associated with the autophagy-lysosome pathway and endosome-lysosome system, leading directly to pathological intracellular aggregation, abnormal externalization and re-internalization cycling (and, in turn, internalization and re-externalization), and exocytosis. Based on these pathological changes, an increasing number of researchers have focused on these new therapeutic targets, aiming at alleviating the pathological accumulation of α-syn and re-establishing normal degradation.
         datePublished:2012-09-08T00:00:00Z
         dateModified:2012-09-08T00:00:00Z
         pageStart:649
         pageEnd:657
         sameAs:https://doi.org/10.1007/s12264-012-1263-1
         keywords:
            Parkinson’s disease
            α-synuclein
            neurodegenerative disease
            Neurosciences
            Human Physiology
            Anesthesiology
            Anatomy
            Neurology
            Pain Medicine
         image:
         isPartOf:
            name:Neuroscience Bulletin
            issn:
               1995-8218
               1673-7067
            volumeNumber:28
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Tian-Fang Jiang
               affiliation:
                     name:Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
                     address:
                        name:Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sheng-Di Chen
               affiliation:
                     name:Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
                     address:
                        name:Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Dysfunction of two lysosome degradation pathways of α-synuclein in Parkinson’s disease: potential therapeutic targets?
      description:Parkinson’s disease (PD) is pathologically characterized by the presence of α-synuclein (α-syn)-positive intracytoplasmic inclusions named Lewy bodies in the dopaminergic neurons of the substantia nigra. A series of morbid consequences are caused by pathologically high amounts or mutant forms of α-syn, such as defects of membrane trafficking and lipid metabolism. In this review, we consider evidence that both point mutation and overexpression of α-syn result in aberrant degradation in neurons and microglia, and this is associated with the autophagy-lysosome pathway and endosome-lysosome system, leading directly to pathological intracellular aggregation, abnormal externalization and re-internalization cycling (and, in turn, internalization and re-externalization), and exocytosis. Based on these pathological changes, an increasing number of researchers have focused on these new therapeutic targets, aiming at alleviating the pathological accumulation of α-syn and re-establishing normal degradation.
      datePublished:2012-09-08T00:00:00Z
      dateModified:2012-09-08T00:00:00Z
      pageStart:649
      pageEnd:657
      sameAs:https://doi.org/10.1007/s12264-012-1263-1
      keywords:
         Parkinson’s disease
         α-synuclein
         neurodegenerative disease
         Neurosciences
         Human Physiology
         Anesthesiology
         Anatomy
         Neurology
         Pain Medicine
      image:
      isPartOf:
         name:Neuroscience Bulletin
         issn:
            1995-8218
            1673-7067
         volumeNumber:28
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Tian-Fang Jiang
            affiliation:
                  name:Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
                  address:
                     name:Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sheng-Di Chen
            affiliation:
                  name:Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
                  address:
                     name:Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Neuroscience Bulletin
      issn:
         1995-8218
         1673-7067
      volumeNumber:28
Organization:
      name:Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
      address:
         name:Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
         type:PostalAddress
      name:Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
      address:
         name:Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Tian-Fang Jiang
      affiliation:
            name:Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
            address:
               name:Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Sheng-Di Chen
      affiliation:
            name:Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
            address:
               name:Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
      name:Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(138)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.39s.

LINK . SPRINGER . COM {}